Study of INCB161734 in people with kidney problems
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests an experimental drug called INCB161734 in people with severe kidney disease or those on dialysis. It aims to see how the drug behaves in the body and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have severe kidney disease or are on dialysis.
- Your kidney function has been stable recently.
- You can swallow and keep down oral tablets.
- You agree to use contraception or not father children during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
This study looks at how a new oral drug (called INCB161734) is processed by the body and how safe it is in people with liver problems. It may help doctors understand the right dose for patients with liver impairment.
This study tests how a new experimental medicine (INCB123667) works and is tolerated in adults with moderate to severe liver problems. Researchers want to understand how the body processes this drug and whether it's safe in people with liver dysfunction.
This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.
This study tests how the body handles an investigational drug called PKN605 in people with different levels of kidney function. It aims to see if the drug is safe and how it is processed when kidneys are impaired, which can help doctors decide the right dose for people with kidney disease.
This study tests a single dose of an investigational medicine (NNC0537-1482) to see how it moves through the body in people with different levels of kidney function. It may help researchers understand how the drug is processed so it can be dosed safely in future studies.
Hear when a new Renal Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.